Plandai Biotech Valuation
| PLPL Stock | USD 0.0001 0.00 0.00% |
Plandai Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Plandai Biotech from analyzing the company fundamentals such as Return On Asset of -0.21, price to sales of 1.04 X, and Shares Outstanding of 263.19 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Plandai Biotech's price fluctuation is out of control at this time. Calculation of the real value of Plandai Biotech is based on 3 months time horizon. Increasing Plandai Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Plandai pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Plandai Biotech. Since Plandai Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Plandai Pink Sheet. However, Plandai Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 9.9E-5 | Naive 1.12E-4 |
The intrinsic value of Plandai Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Plandai Biotech's stock price.
Estimating the potential upside or downside of Plandai Biotech helps investors to forecast how Plandai pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Plandai Biotech more accurately as focusing exclusively on Plandai Biotech's fundamentals will not take into account other important factors: Plandai Biotech Total Value Analysis
Plandai Biotech is at this time projected to have valuation of 236.87 K with market capitalization of 276.35 K, debt of 50.53 K, and cash on hands of 7.96 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Plandai Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
236.87 K | 276.35 K | 50.53 K | 7.96 K |
Plandai Biotech Investor Information
The company recorded a loss per share of 0.03. Plandai Biotech had not issued any dividends in recent years. The entity had 1:2000 split on the 19th of September 2008. Plandai Biotech is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Plandai Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Plandai Biotech has an asset utilization ratio of 6.04 percent. This suggests that the Company is making $0.0604 for each dollar of assets. An increasing asset utilization means that Plandai Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Plandai Biotech Profitability Analysis
The company reported the previous year's revenue of 411.99 K. Net Loss for the year was (4.01 M) with loss before overhead, payroll, taxes, and interest of (768.91 K).About Plandai Biotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Plandai Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Plandai Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Plandai Biotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Plandai Biotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Plandai Biotech. We calculate exposure to Plandai Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Plandai Biotech's related companies.Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.
8 Steps to conduct Plandai Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Plandai Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Plandai Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Plandai Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Plandai Biotech's revenue streams: Identify Plandai Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Plandai Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Plandai Biotech's growth potential: Evaluate Plandai Biotech's management, business model, and growth potential.
- Determine Plandai Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Plandai Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Plandai Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Plandai Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -44.7 M |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.